Li-Bo Tang

7PUBLICATIONS
18CO-AUTHORS
Traditional, complementary and integrative medicine not elsewhere classifiedMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 13, 2026
Correction: Huang et al. Non-Coding RNA: Dual Effects on Breast Cancer Metastasis and Clinical Applications. Cancers 2019, 11, 1802.

|Jan 06, 2026
Multiple Primary Lung Cancer With Driver Gene Mutations: Is Targeted Therapy Always the Optimal Choice?-A Case Report.

Zi-Rui Ren, Lv Wu, Chang Lu

|Jun 09, 2025
Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer.

Li-Bo Tang, Ying-Long Peng, Ji Chen

|Mar 21, 2025
Partial response to lorlatinib in thoracic inflammatory myofibroblastic tumor harboring complex and rare ALK fusions: a case report.

Li-Bo Tang, Ying-Long Peng, Xiao-Rong Yang

|Feb 27, 2025
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases.

Mei-Mei Zheng, Qing Zhou, Hua-Jun Chen

|Jul 30, 2021
Effects of shikonin on the development of ovarian follicles and female germline stem cells.

Shu-Xin Ma, Li-Bo Tang, Zhi-Hang Chen

Pageof 2

Frequent Collaborators

2 joint publications

Qi-Yuan Huang

2 joint publications

Li-Xia Xiong

2 joint publications

Mei-Mei Zheng

2 joint publications

Qing Zhou